Sector consensus Arrowhead Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2026 BST			5-day change	1st Jan Change
81.04 ^USD	+5.87%		+10.51%	+22.07%

06-16	Arrowhead Pharmaceuticals, Inc. Announces Appointment of Dr. Matt Cohen as Director, Effective June 12, 2026	CI
06-10	Arrowhead Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 07:58 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
ARROWHEAD PHARMACEUTICALS, INC.			88.17	+15.18%	12
ARGENX SE			849.01	+12.33%	15
WUXI APPTEC CO., LTD.			145.96	+48.7%	16
BIONTECH SE			106.75	+38.39%	20
INSMED INCORPORATED			197.14	+106.39%	21
WUXI BIOLOGICS (CAYMAN) INC.			40.45	+55.97%	22
GENMAB A/S			2,313.13	+48.66%	15
EXELIXIS, INC.			49	-5.95%	16
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			547.64	+28.74%	17
MADRIGAL PHARMACEUTICALS, INC.			678.71	+35.42%	14
PHARMAESSENTIA CORPORATION			810.5	-18.21%	6
SUMMIT THERAPEUTICS INC.			21.28	+105.34%	13
AKESO, INC.			148.7	+103.57%	20
NUVALENT, INC.			128.12	+3.84%	16
CYTOKINETICS, INCORPORATED			104.7	+39.21%	20
REMEGEN CO., LTD.			99.01	+67.55%	14
IMMUNITYBIO, INC.			13	+93.45%	3
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	770,000	+69.79%	1
SPYRE THERAPEUTICS, INC.			99.13	+18.85%	15
Average			40,865.28	+45.64%	15
Weighted average by Cap.			19,480.51	+41.57%	16